Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 2, 2017
Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ StudyDavid W Dempster, Hua Zhou, Valerie A Ruff, et al.Current Medical Research and Opinion|August 7, 2009
Patient experience with a new teriparatide delivery deviceRobin K Dore, Robert G Feldman, Kathleen A Taylor, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2005
Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) studyPaul D Miller, Stuart L Silverman, Deborah T Gold, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatmentAmelia E B Moore, Glen M Blake, Kathleen A Taylor, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2011
Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosisAmelia E B Moore, Glen M Blake, Kathleen A Taylor, et al.The New England Journal of Medicine|November 16, 2007
Teriparatide or alendronate in glucocorticoid-induced osteoporosisKenneth G Saag, Elizabeth Shane, Steven Boonen, et al.Bone|January 12, 2010
Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronateAlan L Burshell, Rüdiger Möricke, Ricardo Correa-Rotter, et al.Bone|January 16, 2021
Mineral and organic matrix composition at bone forming surfaces in postmenopausal women with osteoporosis treated with either teriparatide or zoledronic acidEleftherios P Paschalis, David W Dempster, Sonja Gamsjaeger, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 3, 2016
Differential Effects of Teriparatide and Zoledronic Acid on Bone Mineralization Density Distribution at 6 and 24 Months in the SHOTZ StudyDavid W Dempster, Paul Roschger, Barbara M Misof, et al.Bone|July 2, 2022
Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control valuesEleftherios P Paschalis, Sonja Gamsjaeger, Klaus Klaushofer, et al.Pageof 2